GB9905416D0 - Small molecules having GLP-2 like activity - Google Patents

Small molecules having GLP-2 like activity

Info

Publication number
GB9905416D0
GB9905416D0 GBGB9905416.5A GB9905416A GB9905416D0 GB 9905416 D0 GB9905416 D0 GB 9905416D0 GB 9905416 A GB9905416 A GB 9905416A GB 9905416 D0 GB9905416 D0 GB 9905416D0
Authority
GB
United Kingdom
Prior art keywords
glp
activity
small molecules
molecules
small
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9905416.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allelix Biopharmaceuticals Inc
Original Assignee
Allelix Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allelix Biopharmaceuticals Inc filed Critical Allelix Biopharmaceuticals Inc
Priority to GBGB9905416.5A priority Critical patent/GB9905416D0/en
Publication of GB9905416D0 publication Critical patent/GB9905416D0/en
Priority to PCT/CA2000/000245 priority patent/WO2000053208A2/en
Priority to AU32659/00A priority patent/AU3265900A/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9905416.5A 1999-03-09 1999-03-09 Small molecules having GLP-2 like activity Ceased GB9905416D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9905416.5A GB9905416D0 (en) 1999-03-09 1999-03-09 Small molecules having GLP-2 like activity
PCT/CA2000/000245 WO2000053208A2 (en) 1999-03-09 2000-03-09 Small molecules having glp-2 like activity
AU32659/00A AU3265900A (en) 1999-03-09 2000-03-09 Small molecules having glp-2 like activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9905416.5A GB9905416D0 (en) 1999-03-09 1999-03-09 Small molecules having GLP-2 like activity

Publications (1)

Publication Number Publication Date
GB9905416D0 true GB9905416D0 (en) 1999-05-05

Family

ID=10849283

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9905416.5A Ceased GB9905416D0 (en) 1999-03-09 1999-03-09 Small molecules having GLP-2 like activity

Country Status (3)

Country Link
AU (1) AU3265900A (en)
GB (1) GB9905416D0 (en)
WO (1) WO2000053208A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001041779A2 (en) * 1999-12-08 2001-06-14 1149336 Ontario Inc. Combined use of glp-2 receptor agonist and chemotherapeutic agent in treatment
EP1970072A1 (en) 2000-09-18 2008-09-17 Sanos Bioscience A/S Use of GLP-2 peptides for the treatment of hyperparathyroidism
US7371721B2 (en) 2000-09-18 2008-05-13 Sanos Bioscience A/S Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
JP4926473B2 (en) * 2003-03-27 2012-05-09 協和発酵キリン株式会社 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND PHARMACEUTICAL COMPRISING THE SAME
AU2006290908C1 (en) 2005-09-14 2014-04-03 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetes
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
JP5711270B2 (en) 2010-02-03 2015-04-30 武田薬品工業株式会社 Apoptosis signal-regulating kinase 1 inhibitor
FR3072875B1 (en) * 2017-10-31 2020-11-06 Adocia COMPOSITION CONSISTING OF A GLP-2 RECEPTOR AGONIST AND A CO-POLYAMINOACID CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
FR3079414B1 (en) * 2018-03-27 2020-05-01 Adocia COMPOSITION COMPRISING A GLP-2 RECEPTOR AGONIST AND A CO-POLYAMINOACID CARRYING CARBOXYLATE LOADS AND HYDROPHOBIC RADICALS
WO2019086559A1 (en) * 2017-10-31 2019-05-09 Adocia Composition comprising a glp-2 receptor agonist and a co-polyamino acid carrying carboxylate charges and hydrophobic radicals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2168136A1 (en) * 1972-01-17 1973-08-31 Ferlux 2-aminobenzoyl hydrazones - with antiinflammatory, analgesic and antipyretic activity
CA2236519C (en) * 1997-05-02 2011-09-13 1149336 Ontario Inc. Methods of enhancing functioning of the large intestine
JP4699576B2 (en) * 1997-05-16 2011-06-15 １１４９３３６ オンタリオ インコーポレーテッド How to strengthen the function of the upper gastrointestinal tract

Also Published As

Publication number Publication date
WO2000053208A2 (en) 2000-09-14
AU3265900A (en) 2000-09-28
WO2000053208A3 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
EP1230462A4 (en) Hoardings
GB9903584D0 (en) Modified calycins
GB2363568B (en) Castor assemblies
EP1147213A4 (en) Novel rgs-containing molecules and uses thereof
GB9905416D0 (en) Small molecules having GLP-2 like activity
AUPP810399A0 (en) Catalytic molecules
GB2353137B (en) Banners
GB9914473D0 (en) Wheel structure
GB9905324D0 (en) Support ststem
GB9924902D0 (en) Posters
GB0027081D0 (en) Solution
GB0010909D0 (en) Support Assemblies
GB9904170D0 (en) Support
GB9913908D0 (en) Willheel support
GB9919544D0 (en) Support
GB9912635D0 (en) Molecules
GB2357543B (en) Structural members
GB9930252D0 (en) Biologically active molecules
CA87867S (en) Easel
GB9921211D0 (en) Catalysis
GB9908730D0 (en) Modified carbohydrate
GB9908731D0 (en) Modified carbohydrate
AU139611S (en) Bookshelf
GB9919106D0 (en) Pharmaceuticals
GB9905063D0 (en) Pharmaceuticals

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)